Benchmarks ended in negative territory for the fifth-straight session on Thursday following the Swiss National Bank’s surprise move to drop its long-standing exchange rate of the Swiss franc against euro. Moreover, disappointing earnings results from Bank of America and Citigroup, and dismal economic data weighed on markets. Also, another decline in oil prices dragged down energy shares on Thursday. The […]
Benchmarks enjoyed their best day this year on Wednesday as the Fed issued encouraging statements regarding economic growth in the U.S. and a rate hike. Fed’s statement that it would remain “patient” before raising the interest rate boosted investor confidence. Moreover, rebound in oil prices helped energy shares post solid gains yesterday. The S&P 500 registered its best one-day gain […]
Benchmarks settled in the green on Wednesday due to gains in technology and telecom stocks. The S&P 500 and the Dow closed at a record level for the 47th and 30th times this year, respectively. Separately, the Nasdaq was boosted by gains in bio-tech stocks. However, the gains were limited by another slump in energy shares. Meanwhile, the day’s discouraging […]
Benchmarks ended in the green zone on Thursday as upbeat economic reports and strong retail earnings results offset dismal data from the Euro-zone and China. Moreover, Intel’s encouraging earnings outlook helped tech shares to post solid gains. Rebound in oil prices boosted energy shares. The Dow and S&P 500 registered yet another record high.For a look at the issues currently […]
Markets retreated from record highs on Wednesday to finish in the red as Fed minutes failed to provide any clear indications about a possible rate hike. Moreover, mixed housing data also weighed on investor sentiment. However, upbeat earning results helped retail stocks to post solid gains on Wednesday.For a look at the issues currently facing the markets, make sure to […]
Rally in healthcare stocks and easing global growth worries boosted benchmarks to finish in the green on Tuesday. Improved investor confidence data from Germany and positive news from Japan reduced worries about the global growth. Encouraging economic data also lifted investor confidence. The S&P 500 and Dow finished at a record high yesterday.For a look at the issues currently facing […]
3 Biotech Stocks for Earnings Beats this SeasonEven a quarter back, tax inversion deals were quite a rage among most of the U.S. based biotech firms. However, these tax dodging strategies have fallen apart ever since the U.S. Department of Treasury issued a notice related to tax inversion deals. We have seen AbbVie Inc. ( ABBV ) calling off its […]
Biotech stocks and the related ETFs have been the star performers this year despite some temporary glitches and rough trading in between. Encouraging industry trends, increasing merger and acquisition activities, expansion into emerging markets and ever-increasing health care spending led the sector to easily outperform the broader U.S. equity markets.Though lofty valuations and regulatory concerns did bring in some pain […]
Markets ended in the green as Russian president’s comments eased concerns related to geopolitical tensions. This, along with positive earnings results, offset jitters over downbeat European growth numbers. Moreover, dismal initial claims data turned out to be positive for the market as it eased sooner-than-expected rate hike fears. Trading volume was very low, making it the second-lowest full trading session […]
Benchmarks ended in the green as gains in biotech stocks offset discouraging retail sales numbers. Disappointing retail sales also negated concerns about a sooner-than-expected interest rate hike. Healthcare and technology stocks helped the S&P to hit a two-week high. However, disappointing earnings from Macy’s eroded some of yesterday’s gains.For a look at the issues currently facing the markets, make sure […]
